Clinical Trials Directory

Trials / Unknown

UnknownNCT01460212

Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Study hypothesis: psychotherapy and SSRI treatment effect in different brain way: psychotherapy in "up to down" way and SSRI in "down to up" way. The investigators will explore this hypothesis in major depressive disorder outpatients with Magnetic Resonance Imaging analysis in this study. Patients in different groups will be treated by psychotherapy or SSRI treatment. They will all be checked with Magnetic Resonance Imaging pro and after 12 weeks of treatment.

Detailed description

Patients meeting the inclusion criteria undergo an examination that included a diagnostic interview, vision test, and psychophysiological measures. Participants then undergo the baseline fMRI scan within 48 hours, after that, they will receive psychotherapy or SSRI treatment.and returned the scan once they completed the therapy.

Conditions

Interventions

TypeNameDescription
DRUGSSRI antidepressantsSSRI antidepressants are Selective serotonin reuptake inhibitors. They include fluoxetine (Prozac); sertraline (Zoloft); paroxetine (Paxil); citalopram (Celexa) ;escitalopram (Lexapro) and fluvoxamine (Luvox). It will be chosen according to special condition of every patient.
BEHAVIORALCognitive-Behavior TherapyThe essence of CBT is a learning process through which an appropriate pattern in cognitive and behavioral could be learn and stored as memory

Timeline

Start date
2011-12-01
Primary completion
2014-12-01
Completion
2015-10-01
First posted
2011-10-26
Last updated
2014-09-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01460212. Inclusion in this directory is not an endorsement.